Literature DB >> 16470522

Regulated release of VWF and FVIII and the biologic implications.

S L Haberichter1, Q Shi, R R Montgomery.   

Abstract

von Willebrand factor (VWF) performs a critical function in platelet binding at the site of vascular injury and also serves as the carrier protein for coagulation factor FVIII (FVIII), protecting it from proteolytic degradation in plasma. Both proteins undergo rapid, regulated release in response to DDAVP administration in patients with mild hemophilia A or von Wille-brand disease. Here, we attempt to summarize our current understanding of the establishment of the regulated storage pool of VWF and FVIII. The data presented indicate that regulated secretion of both proteins occurs only if there is endogenous synthesis of FVIII together with VWF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470522     DOI: 10.1002/pbc.20658

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  17 in total

1.  VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Authors:  Daniel B Bellissimo; Pamela A Christopherson; Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Amy D Shapiro; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Jeanne M Lusher; Margaret V Ragni; Robert R Montgomery
Journal:  Blood       Date:  2011-12-23       Impact factor: 22.113

2.  Markers of vascular perturbation correlate with airway structural change in asthma.

Authors:  Mats W Johansson; Stanley J Kruger; Mark L Schiebler; Michael D Evans; Ronald L Sorkness; Loren C Denlinger; William W Busse; Nizar N Jarjour; Robert R Montgomery; Deane F Mosher; Sean B Fain
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

Review 3.  Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Authors:  Richard Torres; Yuri Fedoriw
Journal:  Clin Lab Med       Date:  2009-06       Impact factor: 1.935

4.  [Acral necrosis in metastatic ovarian carcinoma. A single episode of Moschowitz syndrome during gemcitabine chemotherapy].

Authors:  M J Behne; U Hauswirth; A Menz; N Brüllke; U Müllerleile; I Moll
Journal:  Hautarzt       Date:  2008-11       Impact factor: 0.751

Review 5.  The use of desmopressin in acquired haemophilia A: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2011-07-18       Impact factor: 3.443

6.  Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A.

Authors:  Qizhen Shi; Scot A Fahs; Erin L Kuether; Brian C Cooley; Hartmut Weiler; Robert R Montgomery
Journal:  Blood       Date:  2010-07-06       Impact factor: 22.113

7.  Humanized GPIbα-von Willebrand factor interaction in the mouse.

Authors:  Sachiko Kanaji; Jennifer N Orje; Taisuke Kanaji; Yuichi Kamikubo; Yosuke Morodomi; Yunfeng Chen; Alessandro Zarpellon; Jerome Eberhardt; Stefano Forli; Scot A Fahs; Rashmi Sood; Sandra L Haberichter; Robert R Montgomery; Zaverio M Ruggeri
Journal:  Blood Adv       Date:  2018-10-09

8.  Molecular requirements for sorting of the chemokine interleukin-8/CXCL8 to endothelial Weibel-Palade bodies.

Authors:  Johanna Hol; Axel M Küchler; Finn-Eirik Johansen; Bjørn Dalhus; Guttorm Haraldsen; Inger Oynebråten
Journal:  J Biol Chem       Date:  2009-07-03       Impact factor: 5.157

9.  Collagen binding provides a sensitive screen for variant von Willebrand disease.

Authors:  Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Pamela A Christopherson; Paula M Jacobi; Raymond G Hoffmann; Robert R Montgomery; Sandra L Haberichter
Journal:  Clin Chem       Date:  2013-01-22       Impact factor: 8.327

10.  Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo.

Authors:  Junliang Pan; Thanh Theresa Dinh; Anusha Rajaraman; Mike Lee; Alexander Scholz; Cathrin J Czupalla; Helena Kiefel; Li Zhu; Lijun Xia; John Morser; Haiyan Jiang; Laura Santambrogio; Eugene C Butcher
Journal:  Blood       Date:  2016-05-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.